Skip to main content
Fig. 8 | Diagnostic Pathology

Fig. 8

From: Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy

Fig. 8

BCSS relationship between the ER-/PR + and ER + /PR any groups (Kaplan–Meier method and log-rank test) Legend: Regardless of how PR was expressed, when patients were positive for ER expression, their BCSS was significantly better than that of patients with ER-/PR + phenotypes (log-rank, P < 0.001). Abbreviation: ER, estrogen receptor; PR, progesterone receptor

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us